rs778149316
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_015272.5(RPGRIP1L):c.1709dupA(p.Asp571GlyfsTer12) variant causes a frameshift change. The variant allele was found at a frequency of 0.0000304 in 1,612,168 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_015272.5 frameshift
Scores
Clinical Significance
Conservation
Publications
- Meckel syndrome, type 5Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
- Joubert syndrome 7Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- COACH syndrome 1Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Joubert syndrome with renal defectInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Meckel syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152166Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000400 AC: 10AN: 250264 AF XY: 0.0000443 show subpopulations
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1460002Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 10AN XY: 726426 show subpopulations
GnomAD4 genome AF: 0.000158 AC: 24AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74340 show subpopulations
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Observed with a second RPGRIP1L variant in a patient with Joubert syndrome in published literature (PMID: 26092869); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 31964843, 26092869) -
- -
- -
RPGRIP1L-related disorder Pathogenic:1
The RPGRIP1L c.1709dupA variant is predicted to result in a frameshift and premature protein termination (p.Asp571Glyfs*12). This variant has been reported in the compound heterozygous state in a patient with Joubert syndrome (Table S5, Bachmann-Gagescu et al. 2015. PubMed ID: 26092869). Furthermore, loss of function variants in the RPGRIP1L gene are a known mechanism of disease (Delous et al. 2007. PubMed ID: 17558409). In summary, we classify this variant as pathogenic. -
Joubert syndrome 7 Pathogenic:1
- -
Joubert syndrome Pathogenic:1
- -
Meckel syndrome, type 5;C1969053:Joubert syndrome 7;C5436841:COACH syndrome 3 Pathogenic:1
- -
Meckel-Gruber syndrome;C0431399:Joubert syndrome Pathogenic:1
This sequence change creates a premature translational stop signal (p.Asp571Glyfs*12) in the RPGRIP1L gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RPGRIP1L are known to be pathogenic (PMID: 17558409). This variant is present in population databases (rs778149316, gnomAD 0.04%). This premature translational stop signal has been observed in individual(s) with Joubert syndrome (PMID: 26092869). ClinVar contains an entry for this variant (Variation ID: 188192). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at